SCHEMBL5145067

SCHEMBL5145067

CC(C)(C)c1ccnc(NC(=O)Nc2ccc(-c3cc(CN4CCOCC4)n4ncnc([AsH2])c34)cc2Cl)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACVRL1 P37023 5/20 0.48
MAPK14 Q16539 1/20 0.42
RET P07949 2/20 0.42
MAPK9 P45984 3/20 0.39
FGFR1 P11362 2/20 0.39
BCR P11274 1/20 0.39
FLT3 P36888 1/20 0.39
FRK P42685 1/20 0.39
RPS6KA3 P51812 1/20 0.39
PRKCD Q05655 1/20 0.39
DDR1 Q08345 1/20 0.39
MAP4K2 Q12851 1/20 0.39
TNK1 Q13470 1/20 0.39
RPS6KA1 Q15418 1/20 0.39
MAP3K11 Q16584 1/20 0.39
DDR2 Q16832 1/20 0.39
RPS6KA6 Q9UK32 1/20 0.39
KDR P35968 4/20 0.38
MOK Q9UQ07 3/20 0.38
MERTK Q12866 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL58527 0.92 ACVRL1 (0.59) ACVRL1MAPK14RETMAPK9FGFR1
SCHEMBL58758 0.86 ACVRL1 (0.59) ACVRL1RETMAPK9FGFR1BCR
SCHEMBL59023 0.84 ACVRL1 (0.60) ACVRL1MAPK14RETMAPK9FGFR1
SCHEMBL59349 0.83 ACVRL1 (0.55) ACVRL1MAPK14RETMAPK9FGFR1
SCHEMBL58322 0.82 ACVRL1 (0.61) ACVRL1RETMAPK9FGFR1BCR
SCHEMBL59430 0.81 ACVRL1 (0.52) ACVRL1MAPK14RETMAPK9FGFR1
SCHEMBL59381 0.80 ACVRL1 (0.59) ACVRL1MAPK14RETMAPK9FGFR1
SCHEMBL58291 0.79 ACVRL1 (0.59) ACVRL1RETMAPK9FGFR1BCR
SCHEMBL65977 0.78 RET (0.59) ACVRL1RETMAPK9FGFR1BCR
SCHEMBL58558 0.78 RET (0.54) ACVRL1MAPK14RETMAPK9FGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1957485-A2 SUBSTITUTED 4-AMINO-PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS Bayer Healthcare, LLC (US) 2008-08-20 EP disclosed
WO-2007064931-A2 SUBSTITUTED 4-AMINO-PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS BAYER HEALTHCARE LLC (US) 2007-06-07 WO disclosed